Spots Global Cancer Trial Database for stage ii pancreatic cancer
Every month we try and update this database with for stage ii pancreatic cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Radiation Therapy Plus Chemotherapy in Treating Patients With Pancreatic Cancer | NCT00002689 | Pancreatic Canc... | dexamethasone fluorouracil brachytherapy phosphorus P32 radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer | NCT00274885 | Cancer | oxaliplatin management of t... | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | NCT00003216 | Pancreatic Canc... | fluorouracil gemcitabine hyd... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic Cancer | NCT00547612 | Pancreatic Canc... | high performanc... pharmacological... [18F]-labeled s... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Adjuvant GVAX Vaccine Therapy in Patients With Pancreatic Cancer | NCT00389610 | Pancreatic Canc... | GVAX pancreas v... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| BMS-247550 in Treating Patients With Advanced Pancreatic Cancer | NCT00016965 | Pancreatic Canc... | ixabepilone | 18 Years - | National Cancer Institute (NCI) | |
| Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine | NCT00053222 | Pancreatic Canc... | arsenic trioxid... | 18 Years - | University of Chicago | |
| Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer | NCT00003025 | Pancreatic Canc... | vitespen | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Eribulin Mesylate as Second-Line Therapy for Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer Patients | NCT00383760 | Adenocarcinoma ... Pancreatic Canc... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | eribulin mesyla... | 18 Years - | National Cancer Institute (NCI) | |
| Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid Tumors | NCT00352131 | Non-colorectal ... Pancreatic Canc... | HuC242-DM4 | 18 Years - | ImmunoGen, Inc. | |
| Perifosine in Treating Patients With Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer | NCT00059982 | Pancreatic Canc... | perifosine | 18 Years - | National Cancer Institute (NCI) | |
| Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | NCT00058201 | Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... clinical observ... | 18 Years - | National Cancer Institute (NCI) | |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
| Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer | NCT00003411 | Extrahepatic Bi... Gallbladder Can... Pancreatic Canc... | motexafin gadol... radiation thera... | 18 Years - 120 Years | University of Pittsburgh | |
| Chemoradiation in Locally Advanced Pancreatic Cancer | NCT00262951 | Pancreatic Canc... | recombinant int... cisplatin fluorouracil radiation thera... Resection of tu... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer | NCT00004861 | Pancreatic Canc... | gemcitabine hyd... tacedinaline | 18 Years - | Pfizer | |
| Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery | NCT00004895 | Colorectal Canc... Constipation, I... Extrahepatic Bi... Gastric Cancer Gastrointestina... Nausea and Vomi... Ovarian Cancer Pancreatic Canc... Peritoneal Cavi... Small Intestine... | octreotide acet... | 18 Years - | Northwestern University | |
| Chemotherapy Compared to Biological Therapy in Treating Patients With Cancer of the Pancreas | NCT00003780 | Pancreatic Canc... | tumor infiltrat... gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer | NCT00002475 | Breast Cancer Colorectal Canc... Kidney Cancer Lung Cancer Malignant Mesot... Pancreatic Canc... | allogeneic tumo... autologous tumo... recombinant int... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Nitrocamptothecin Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | NCT00005869 | Pancreatic Canc... | gemcitabine hyd... rubitecan | 18 Years - | National Cancer Institute (NCI) | |
| Individualized Drug Treatment for Treating Patients With Pancreatic Cancer | NCT00276744 | Pancreatic Canc... | cetuximab capecitabine docetaxel Erlotinib Gemcitabine Irinotecan mitomycin C rapamycin conventional su... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Gemcitabine With or Without Tipifarnib (R115777) in Treating Patients With Advanced Pancreatic Cancer | NCT00005648 | Pancreatic Neop... | Gemcitabine wit... Gemcitabine wit... | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Erlotinib, Gemcitabine, and Radiation Therapy in Treating Patients With Locally Advanced Unresectable Pancreatic Cancer | NCT00063947 | Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... | erlotinib hydro... gemcitabine hyd... radiation thera... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal Cancer | NCT00478010 | Colorectal Canc... Pancreatic Canc... Psychosocial Ef... | counseling inte... study of socioe... psychosocial as... quality-of-life... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | NCT00003125 | Breast Cancer Esophageal Canc... Gastric Cancer Lung Cancer Pancreatic Canc... Unspecified Adu... | ALVAC-CEA vacci... aldesleukin sargramostim vaccinia-CEA va... | 18 Years - | Georgetown University | |
| Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer | NCT00068575 | Pancreatic Canc... | Recombinant Int... Cisplatin Fluorouracil Radiation Thera... | 18 Years - | M.D. Anderson Cancer Center | |
| ChemoRT With Adjuvant Chemo in Pancreatic Cancer (TARCEVA) | NCT00313560 | Pancreatic Canc... | erlotinib hydro... | 18 Years - 100 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemotherapy Plus Radiation Therapy With or Without Tipifarnib in Treating Patients With Locally Advanced Pancreatic Cancer | NCT00026104 | Adenocarcinoma ... Stage II Pancre... Stage III Pancr... | gemcitabine hyd... paclitaxel tipifarnib radiation thera... | - | National Cancer Institute (NCI) | |
| Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma | NCT00075452 | Pancreatic Canc... | gemcitabine hyd... oxaliplatin | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer | NCT00544193 | Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | gemcitabine hyd... polymerase chai... immunohistochem... conventional su... intraoperative ... radiation thera... | 18 Years - 70 Years | City of Hope Medical Center | |
| Vaccine Therapy in Treating Patients With Stage I or Stage II Pancreatic Cancer | NCT00003025 | Pancreatic Canc... | vitespen | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders | NCT00830557 | Islet Cell Tumo... Pancreatic Canc... Pancreatic Dise... | medical chart r... survey administ... biospecimen col... | 18 Years - 120 Years | Mayo Clinic | |
| Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery | NCT00003798 | Pancreatic Canc... | motexafin gadol... radiation thera... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Pancreatic Cancer Collaborative Registry | NCT00661882 | Pancreatic Canc... | medical chart r... questionnaire a... study of socioe... biopsy | 19 Years - 100 Years | University of Nebraska | |
| Individualized Drug Treatment for Treating Patients With Pancreatic Cancer | NCT00276744 | Pancreatic Canc... | cetuximab capecitabine docetaxel Erlotinib Gemcitabine Irinotecan mitomycin C rapamycin conventional su... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Pancreatic, Esophageal, Stomach, Colon, or Rectal Cancer | NCT00010270 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | National Cancer Institute (NCI) | |
| Fluorouracil, External-Beam Radiation Therapy, and Gemcitabine With or Without Brachytherapy Using Phosphorus P32 in Treating Patients With Locally or Regionally Advanced Unresectable Adenocarcinoma of the Pancreas | NCT00079365 | Pancreatic Canc... | fluorouracil gemcitabine hyd... brachytherapy phosphorus P32 radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | NCT00369109 | Breast Cancer Colorectal Canc... Pancreatic Canc... | biologic sample... immunohistochem... laboratory biom... biopsy | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Vaccine Therapy and Biological Therapy in Treating Patients With Advanced Cancer | NCT00019084 | Breast Cancer Cervical Cancer Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | aldesleukin mutant p53 pept... ras peptide can... sargramostim therapeutic aut... therapeutic tum... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery | NCT00524069 | Pancreatic Canc... | bevacizumab capecitabine gemcitabine hyd... flow cytometry laboratory biom... adjuvant therap... computed tomogr... neoadjuvant the... | 18 Years - | Roswell Park Cancer Institute | |
| Flavopiridol Plus Radiation Therapy Followed By Gemcitabine Hydrochloride in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer | NCT00047307 | Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | alvocidib gemcitabine hyd... 3-dimensional c... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | NCT00095966 | Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | sorafenib tosyl... gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | NCT00088894 | Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | gemcitabine hyd... bevacizumab placebo laboratory biom... pharmacogenomic... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer | NCT03825289 | Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Hydroxychloroqu... Trametinib | 18 Years - | University of Utah | |
| Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer | NCT00436410 | Adrenocortical ... Breast Cancer Colorectal Canc... Gastrointestina... Kidney Cancer Liver Cancer Melanoma (Skin) Ovarian Cancer Pancreatic Canc... Sarcoma | colloidal gold-... electron micros... pharmacological... conventional su... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder | NCT00489515 | Colorectal Canc... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | 18 Years - 120 Years | Wake Forest University Health Sciences | ||
| Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer | NCT00091026 | Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | cetuximab gemcitabine hyd... bevacizumab erlotinib hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy in Treating Patients With Advanced or Metastatic Cancer | NCT00027534 | Breast Cancer Colorectal Canc... Gallbladder Can... Gastric Cancer Head and Neck C... Liver Cancer Ovarian Cancer Pancreatic Canc... Testicular Germ... | TRICOM-CEA(6D) | 18 Years - | Duke University | |
| Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas | NCT00003216 | Pancreatic Canc... | fluorouracil gemcitabine hyd... radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Vaccine Therapy in Treating Patients With Cancer of the Gastrointestinal Tract | NCT00012246 | Colorectal Canc... Esophageal Canc... Extrahepatic Bi... Gallbladder Can... Gastric Cancer Pancreatic Canc... Small Intestine... | carcinoembryoni... incomplete Freu... sargramostim | 18 Years - | The University of Texas Medical Branch, Galveston | |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
| EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer | NCT00087191 | Advanced Adult ... Carcinoma of th... Fallopian Tube ... Gastrointestina... Localized Extra... Localized Gallb... Localized Gastr... Localized Resec... Localized Unres... Metastatic Gast... Ovarian Sarcoma Ovarian Stromal... Primary Periton... Recurrent Adult... Recurrent Adult... Recurrent Colon... Recurrent Extra... Recurrent Gallb... Recurrent Gastr... Recurrent Gastr... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pancr... Recurrent Recta... Recurrent Small... Recurrent Uteri... Regional Gastro... Small Intestine... Small Intestine... Small Intestine... Stage 0 Non-sma... Stage I Adult S... Stage I Colon C... Stage I Gastric... Stage I Non-sma... Stage I Ovarian... Stage I Ovarian... Stage I Pancrea... Stage I Rectal ... Stage I Uterine... Stage II Adult ... Stage II Colon ... Stage II Gastri... Stage II Non-sm... Stage II Ovaria... Stage II Ovaria... Stage II Pancre... Stage II Rectal... Stage II Uterin... Stage III Adult... Stage III Colon... Stage III Gastr... Stage III Ovari... Stage III Ovari... Stage III Pancr... Stage III Recta... Stage III Uteri... Stage IIIA Non-... Stage IIIB Non-... Stage IV Adult ... Stage IV Colon ... Stage IV Gastri... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Pancre... Stage IV Rectal... Stage IV Uterin... Unresectable Ex... Unresectable Ga... | EF5 motexafin lutet... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer | NCT00460174 | Pancreatic Canc... | bevacizumab gemcitabine conventional su... radiation thera... | 18 Years - 120 Years | Northwestern University | |
| Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | NCT00448838 | Pancreatic Canc... | Cetuximab Gemcitabine Hyd... Oxaliplatin | 18 Years - 120 Years | University of Miami | |
| Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | NCT00003049 | Pancreatic Canc... | fluorouracil leucovorin calc... conventional su... radiation thera... | 18 Years - 120 Years | Mayo Clinic | |
| Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer | NCT00019474 | Extrahepatic Bi... Gastric Cancer Gastrointestina... Liver Cancer Pancreatic Canc... Small Intestine... | filgrastim recombinant int... fluorouracil hydroxyurea | 18 Years - 120 Years | Montefiore Medical Center | |
| Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I or Stage II Adenocarcinoma (Cancer) of the Pancreas | NCT00084383 | Pancreatic Canc... | GVAX pancreatic... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer | NCT00082862 | Pancreatic Canc... | recombinant int... cisplatin gemcitabine hyd... hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan and Capecitabine in Treating Patients With Solid Tumors | NCT00003867 | Cancer | capecitabine irinotecan hydr... | 18 Years - 120 Years | Montefiore Medical Center | |
| Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer | NCT00058201 | Pancreatic Canc... | fluorouracil gemcitabine hyd... leucovorin calc... clinical observ... | 18 Years - | National Cancer Institute (NCI) | |
| Bevacizumab and Gemcitabine Combined With Either Cetuximab or Erlotinib in Treating Patients With Advanced Pancreatic Cancer | NCT00091026 | Adenocarcinoma ... Recurrent Pancr... Stage II Pancre... Stage III Pancr... Stage IV Pancre... | cetuximab gemcitabine hyd... bevacizumab erlotinib hydro... | 18 Years - | National Cancer Institute (NCI) | |
| Trametinib and Hydroxychloroquine in Treating Patients With Pancreatic Cancer | NCT03825289 | Metastatic Panc... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... Stage IV Pancre... Unresectable Pa... | Hydroxychloroqu... Trametinib | 18 Years - | University of Utah | |
| Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer | NCT00049348 | Pancreatic Canc... | epoetin alfa filgrastim cisplatin fluorouracil gemcitabine hyd... adjuvant therap... conventional su... neoadjuvant the... radiation thera... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen | NCT00016380 | Cancer | dexamethasone ondansetron quality-of-life... | 16 Years - 120 Years | Canadian Cancer Trials Group | |
| Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer | NCT00003085 | Pancreatic Canc... | laparoscopy ultrasound imag... | 18 Years - | University of Southern California | |
| Immunotoxin Therapy in Treating Patients With Advanced Cancer | NCT00006981 | Cervical Cancer Fallopian Tube ... Head and Neck C... Lung Cancer Malignant Mesot... Ovarian Cancer Pancreatic Canc... Primary Periton... | SS1(dsFv)-PE38 ... | 18 Years - | National Cancer Institute (NCI) | |
| Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors | NCT00019331 | Colorectal Canc... Endometrial Can... Head and Neck C... Liver Cancer Lung Cancer Melanoma (Skin) Pancreatic Canc... Testicular Germ... Unspecified Adu... | aldesleukin ras peptide can... sargramostim DetoxPC | 18 Years - | National Cancer Institute (NCI) | |
| Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | NCT00882765 | Pancreatic Canc... | genistein | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Chemotherapy, Stereotactic Body Radiation Therapy & Nelfinavir Mesylate in Locally Advanced Pancreatic Cancer | NCT01959672 | Pancreatic Aden... Resectable Panc... Stage I Pancrea... Stage IA Pancre... Stage IB Pancre... Stage II Pancre... Stage IIA Pancr... Stage IIB Pancr... Stage III Pancr... | 4-Dimensional C... Fluorouracil Gemcitabine Hyd... Laboratory Biom... Leucovorin Calc... Nelfinavir Mesy... Oregovomab Stereotactic Bo... Therapeutic Con... | 19 Years - | University of Nebraska | |
| Surgery Followed by Radiation Therapy and Chemotherapy in Treating Patients With Cancer of the Pancreas | NCT00003049 | Pancreatic Canc... | fluorouracil leucovorin calc... conventional su... radiation thera... | 18 Years - 120 Years | Mayo Clinic | |
| S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer | NCT00003018 | Pancreatic Canc... | dipyridamole fluorouracil leucovorin calc... mitomycin C | 18 Years - | SWOG Cancer Research Network | |
| Vaccine Therapy, Chemotherapy, and GM-CSF in Treating Patients With Advanced Pancreatic Cancer | NCT00002773 | Pancreatic Canc... | allogeneic tumo... recombinant int... sargramostim cyclophosphamid... | 18 Years - | National Cancer Institute (NCI) | |
| Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine | NCT00053222 | Pancreatic Canc... | arsenic trioxid... | 18 Years - | University of Chicago | |
| Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | NCT00114179 | Adenocarcinoma ... Stage II Pancre... Stage III Pancr... | capecitabine radiation thera... bevacizumab therapeutic con... gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer | NCT00003426 | Pancreatic Canc... | gemcitabine hyd... radiation thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer | NCT00003546 | Pancreatic Canc... | gemcitabine hyd... radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery | NCT00114179 | Adenocarcinoma ... Stage II Pancre... Stage III Pancr... | capecitabine radiation thera... bevacizumab therapeutic con... gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| LMB-9 Immunotoxin in Treating Patients With Advanced Colon, Breast, Non-small Cell Lung, Bladder, Pancreatic, or Ovarian Cancer | NCT00005858 | Bladder Cancer Breast Cancer Colorectal Canc... Lung Cancer Ovarian Cancer Pancreatic Canc... | LMB-9 immunotox... | 18 Years - | University of Maryland, Baltimore |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
